Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

AHRA: 7-step marketing plan propels breast imaging into spotlight

DALLASRadiology services marketing can be viewed as a seven-step process, explained Mike Suddendorf of Premier Radiology Marketing in Columbus, Ohio, at an educational session Aug. 14 at the annual meeting of the AHRA.

FDA proposes benefit-risk guidance for medical devices

The FDA released draft guidance Aug. 15 aimed at clarifying how benefit-risk determinations are made during premarket review of certain medical devices. The administration is accepting comments on the draft until Nov. 14.

Vital nabs FDA approval for universal viewer

Vital Images, a subsidiary of Toshiba Medical Systems Group that develops advanced visualization and analysis technologies for healthcare providers, has received 510(k) clearance from the FDA for VitreaView, a universal viewer that provides uniform access to patient images. VitreaView is designed for access through the EMR, EHR and health information exchange (HIE).

JNM: New PET radiopharmaceutical may be safe for brain imaging

Researchers found the newly-developed radiopharmaceutical C-4DST safe and effective for imaging brain tumors in a pilot study published Aug. 1 in the Journal of Nuclear Medicine.

FDA releases PET drug manufacturing guidelines

The recently released FDA guidance on current good manufacturing practice (cGMP) for PET drugs addresses resources, procedures and documentation expected of facilities, as well as distinguishes between PET drug production practice and pharmacy practice.

Last week for Health Imaging's Top Trends Survey

Health Imaging's annual top trends survey is winding down, but we continue to seek input from our readers.

JACC: Myocardial perfusion imaging by CMR is efficacious for both sexes

In addition to avoiding exposure to ionizing radiation, stress cardiac MR (CMR) myocardial perfusion imaging is an effective and robust risk-stratifying tool for patients of either sex presenting with possible ischemia, according to a study in the August issue of JACC: Cardiovascular Imaging.

JNM: Salvage neoadjuvant radiochemotherapy does not change clinical course

A PET-guided treatment algorithm was proven feasible, according to the results of the MUNICON II trial, published in this months Journal of Nuclear Medicine. However, by comparing the groups of non-responding patients in the current trial and the previous published MUNICON I trial, increased histopathologic response was observed after salvage radiochemotherapy, but the studys primary endpoint to increase the R0 resection rate was not met.

Displaying 7809 - 7816 of 23572

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.